129 related articles for article (PubMed ID: 12828586)
41. Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Cornely OA; Wicke T; Seifert H; Bethe U; Schwonzen M; Reichert D; Ullmann AJ; Karthaus M; Breuer K; Salzberger B; Diehl V; Fätkenheuer G
Int J Hematol; 2004 Jan; 79(1):74-8. PubMed ID: 14979482
[TBL] [Abstract][Full Text] [Related]
42. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
[TBL] [Abstract][Full Text] [Related]
43. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.
Sezgin G; Acipayam C; Ozkan A; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2014; 15(11):4549-53. PubMed ID: 24969883
[TBL] [Abstract][Full Text] [Related]
44. [Clinical, pharmacokinetic and therapeutic study of amikacin with single daily dose and in combination in neutropenic children with fever].
Bertrand Y; Bréant V; Vray C; Nakache C; Barbé G; Dürr F; Aulagner G
Arch Pediatr; 1996 Sep; 3(9):854-60. PubMed ID: 8949344
[TBL] [Abstract][Full Text] [Related]
45. [Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors].
Natali M; Tonini G; Tufo E; Leggio M; Carassai A; Lopez M
Clin Ter; 1989 Sep; 130(5):239-44. PubMed ID: 2530024
[TBL] [Abstract][Full Text] [Related]
46. Ceftriaxone versus aztreonam plus cefazolin for infections in cancer patients with adequate neutrophil counts.
Menichetti F; Del Favero A; Bucaneve G; Minotti V; Patoia L; Pauluzzi S
Infection; 1990; 18(3):166-9. PubMed ID: 2365468
[TBL] [Abstract][Full Text] [Related]
47. Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
Viscoli C; Cometta A; Kern WV; Bock R; Paesmans M; Crokaert F; Glauser MP; Calandra T;
Clin Microbiol Infect; 2006 Mar; 12(3):212-6. PubMed ID: 16451406
[TBL] [Abstract][Full Text] [Related]
48. Timentin (ticarcillin and clavulanic acid) in combination with aminoglycosides in the treatment of febrile episodes in neutropenic children.
Schaison G; Reinert P; Leverger G; Leauté JB
J Antimicrob Chemother; 1986 May; 17 Suppl C():177-81. PubMed ID: 3722043
[TBL] [Abstract][Full Text] [Related]
49. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
Rubenstein EB; Rolston K; Benjamin RS; Loewy J; Escalante C; Manzullo E; Hughes P; Moreland B; Fender A; Kennedy K
Cancer; 1993 Jun; 71(11):3640-6. PubMed ID: 8490912
[TBL] [Abstract][Full Text] [Related]
50. Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children.
Le Guyader N; Auvrignon A; Vu-Thien H; Portier E; Tabone MD; Leverger G
Support Care Cancer; 2004 Oct; 12(10):720-4. PubMed ID: 15138864
[TBL] [Abstract][Full Text] [Related]
51. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP
Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228
[TBL] [Abstract][Full Text] [Related]
52. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
De Pauw BE; Deresinski SC; Feld R; Lane-Allman EF; Donnelly JP
Ann Intern Med; 1994 May; 120(10):834-44. PubMed ID: 8154643
[TBL] [Abstract][Full Text] [Related]
53. Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
Demirkaya M; Celebi S; Sevinir B; Hacımustafaoglu M
Pediatr Hematol Oncol; 2013 Mar; 30(2):141-8. PubMed ID: 23301757
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
[TBL] [Abstract][Full Text] [Related]
55. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
[TBL] [Abstract][Full Text] [Related]
56. [Empirical antimicrobial therapy of infection and fever episodes in children and adolescents with neutropenia caused by cytotoxic chemotherapy].
Fink FM; Frischhut-Schiffer EM; Ausserer B; Allerberger F; Guggenbichler JP
Padiatr Padol; 1989; 24(1):33-42. PubMed ID: 2717190
[TBL] [Abstract][Full Text] [Related]
57. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP
Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770
[TBL] [Abstract][Full Text] [Related]
58. Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.
Martino P; Micozzi A; Gentile G; Raccah R; Girmenia C; Mandelli F
Clin Infect Dis; 1992 Aug; 15(2):290-4. PubMed ID: 1387806
[TBL] [Abstract][Full Text] [Related]
59. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935
[TBL] [Abstract][Full Text] [Related]
60. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]